T/HBIQA 0009-2024 Active Group standards

T/HBIQA 0009-2024 Determination of Concentrations of Seven Multi-Kinase Drugs in Human Blood by High-Performance Liquid Chromatography-Tandem Mass Spectrometry

Publish Date: 2024-08-15 Implement Date: 2024-10-15 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/HBIQA 0009-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Laboratory medicine

Publish Date: 2024-08-15

Implement Date: 2024-10-15

Scope

Main technical content: This document specifies the high-performance liquid chromatography-tandem mass spectrometry method for detecting the content of seven multi-kinase drugs in human blood. This document is applicable to the determination of the content of sorafenib, axitinib, erlotinib, crizotinib, brigatinib, lenvatinib, and gevotinib in human blood.